<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34411281</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><Issue>24</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca<sup>2+</sup> -activated K<sub>Ca</sub> 3.1 channels.</ArticleTitle><Pagination><StartPage>4891</StartPage><EndPage>4906</EndPage><MedlinePgn>4891-4906</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.15665</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Amyotrophic lateral sclerosis (ALS) patients exhibit dysfunctional energy metabolism and weight loss, which is negatively correlated with survival, together with neuroinflammation. However, the possible contribution of neuroinflammation to deregulations of feeding behaviour in ALS has not been studied in detail. We here investigated if microglial K<sub>Ca</sub> 3.1 is linked to hypothalamic neuroinflammation and affects feeding behaviours in ALS mouse models.</AbstractText><AbstractText Label="EXPERIMENTAL APPROACH">hSOD1<sup>G93A</sup> and TDP43<sup>A315T</sup> mice were treated daily with 120&#x2009;mg&#xb7;kg<sup>-1</sup> of TRAM-34 or vehicle by intraperitoneal injection from the presymptomatic until the disease onset phase. Body weight and food intake were measured weekly. The later by weighing food provided minus that left in the cage. RT-PCR and immunofluorescence analysis were used to characterize microglia phenotype and the main populations of melanocortin neurons in the hypothalamus of hSOD1<sup>G93A</sup> and age-matched non-tg mice. The cannabinoid-opioid interactions in feeding behaviour of hSOD1<sup>G93A</sup> mice were studied using an inverse agonist and an antagonist of the cannabinoid receptor CB<sub>1</sub> (rimonabant) and &#x3bc;-opioid receptors (naloxone), respectively.</AbstractText><AbstractText Label="KEY RESULTS">We found that treatment of hSOD1<sup>G93A</sup> mice with the K<sub>Ca</sub> 3.1 inhibitor TRAM-34 (i), attenuates the pro-inflammatory phenotype of hypothalamic microglia, (ii) increases food intake and promotes weight gain, (iii) increases the number of healthy pro-opiomelanocortin (POMC) neurons and (iv), changes the expression of cannabinoid receptors involved in energy homeostasis.</AbstractText><AbstractText Label="CONCLUSION AND IMPLICATIONS">Using ALS mouse models, we describe defects in the hypothalamic melanocortin system that affect appetite control. These results reveal a new regulatory role for K<sub>Ca</sub> 3.1 to counteract weight loss in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cocozza</LastName><ForeName>Germana</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7005-7983</Identifier><AffiliationInfo><Affiliation>Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morotti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chece</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimaldi</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Life Nanoscience, Istituto Italiano di Tecnologia@Sapienza, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lecce</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scavizzi</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>EMMA CNR, Monterotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menghini</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casagrande</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federici</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raspa</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>EMMA CNR, Monterotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wulff</LastName><ForeName>Heike</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4437-5763</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of California, Davis, Davis, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limatola</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053486">Melanocortins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024681">Potassium Channels, Calcium-Activated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043882">Receptors, Cannabinoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C411671">TRAM 34</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="Y">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053486" MajorTopicYN="N">Melanocortins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024681" MajorTopicYN="N">Potassium Channels, Calcium-Activated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043882" MajorTopicYN="N">Receptors, Cannabinoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CSF</Keyword><Keyword MajorTopicYN="N">hypothalamus feeding behaviour</Keyword><Keyword MajorTopicYN="N">ion channels</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>17</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34411281</ArticleId><ArticleId IdType="pmc">PMC9293222</ArticleId><ArticleId IdType="doi">10.1111/bph.15665</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander, S. P. H. , Christopoulos, A. , Davenport, A. P. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , &amp; Pawson, A. J. (2019). The Concise Guide to PHARMACOLOGY 2019/20: G protein&#x2010;coupled receptors. British Journal of Pharmacology, 176(Suppl 1), S21&#x2013;S141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844580</ArticleId><ArticleId IdType="pubmed">31710717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ataga, K. I. , Reid, M. , Ballas, S. K. , Yasin, Z. , Bigelow, C. , James, L. S. , Smith, W. R. , Galacteros, F. , Kutlar, A. , Hull, J. H. , Stocker, J. W. , &amp; ICA&#x2010;17043&#x2010;10 Study Investigators . (2011). Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso&#x2010;occlusive crises in patients with sickle cell disease: A phase III randomized, placebo&#x2010;controlled, double&#x2010;blind study of the Gardos channel blocker senicapoc (ICA&#x2010;17043). British Journal of Haematology, 153(1), 92&#x2013;104. 10.1111/j.1365-2141.2010.08520.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2010.08520.x</ArticleId><ArticleId IdType="pubmed">21323872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ataga, K. I. , Smith, W. R. , De Castro, L. M. , Swerdlow, P. , Saunthararajah, Y. , Castro, O. , Vichinsky, E. , Kutlar, A. , Orringer, E. P. , Rigdon, G. C. , &amp; Stocker, J. W. (2008). Efficacy and safety of the Gardos channel blocker, senicapoc (ICA&#x2010;17043), in patients with sickle cell anemia. Blood, 111(8), 3991&#x2013;3997. 10.1182/blood-2007-08-110098</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-08-110098</ArticleId><ArticleId IdType="pubmed">18192510</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;valos, Y. , Kerr, B. , Maliqueo, M. , &amp; Dorfman, M. (2018). Cell and molecular mechanisms behind diet&#x2010;induced hypothalamic inflammation and obesity. Journal of Neuroendocrinology, 30, e12598. 10.1111/jne.12598</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jne.12598</ArticleId><ArticleId IdType="pubmed">29645315</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzler, J. , Ganjam, G. K. , Pretz, D. , Oelkrug, R. , Koch, C. E. , Legler, K. , St&#xf6;hr, S. , Culmsee, C. , Williams, L. M. , &amp; Tups, A. (2015). Central inhibition of IKK&#x3b2;/NF&#x2010;&#x3ba;B signaling attenuates high&#x2010;fat diet&#x2010;induced obesity and glucose intolerance. Diabetes, 64, 2015&#x2013;2027. 10.2337/db14-0093</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-0093</ArticleId><ArticleId IdType="pubmed">25626735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermudez&#x2010;Silva, F. J. , Cardinal, P. , &amp; Cota, D. (2012). The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology, 26, 114&#x2013;124. 10.1177/0269881111408458</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881111408458</ArticleId><ArticleId IdType="pubmed">21824982</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e, S. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389&#x2013;1392. 10.1126/science.1123511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun, T. P. , &amp; Marks, D. L. (2010). Pathophysiology and treatment of inflammatory anorexia in chronic disease. Journal of Cachexia, Sarcopenia and Muscle, 1, 135&#x2013;145. 10.1007/s13539-010-0015-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13539-010-0015-1</ArticleId><ArticleId IdType="pmc">PMC3060655</ArticleId><ArticleId IdType="pubmed">21475703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y. J. , Raman, G. , Bodendiek, S. , O'Donnell, M. E. , &amp; Wulff, H. (2011). The KCa3.1 blocker TRAM&#x2010;34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke. Journal of Cerebral Blood Flow and Metabolism, 31(12), 2363&#x2013;2374. 10.1038/jcbfm.2011.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.101</ArticleId><ArticleId IdType="pmc">PMC3323185</ArticleId><ArticleId IdType="pubmed">21750563</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, C. I. , Lee, Y. D. , Gwag, B. J. , Cho, S. I. , Kim, S. S. , &amp; Suh&#x2010;Kim, H. (2008). Effects of estrogen on lifespan and motor functions in female hSOD1G93A transgenic mice. Journal of the Neurological Sciences, 268, 40&#x2013;47. 10.1016/j.jns.2007.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.10.024</ArticleId><ArticleId IdType="pubmed">18054961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun&#x2010;Xia, Y. I. , Walter, M. , Gao, Y. , Pitra, S. , Legutko, B. , K&#xe4;lin, S. , Layritz, C. , Garc&#xed;a&#x2010;C&#xe1;ceres, C. , Bielohuby, M. , Bidlingmaier, M. , &amp; Woods, S. C. (2017). TNF&#x3b1; drives mitochondrial stress in POMC neurons in obesity. Nature Communications, 8, 15143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436136</ArticleId><ArticleId IdType="pubmed">28489068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocozza, G. , Di Castro, M. A. , Carbonari, L. , Grimaldi, A. , Antonangeli, F. , Garofalo, S. , Porzia, A. , Madonna, M. , Mainiero, F. , Santoni, A. , &amp; Grassi, F. (2018). Ca2+&#x2010;activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice. Brain, Behavior, and Immunity, 73, 584&#x2013;595. 10.1016/j.bbi.2018.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6129409</ArticleId><ArticleId IdType="pubmed">29981425</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo, G. , Agabio, R. , Diaz, G. , Lobina, C. , Reali, R. , &amp; Gessa, G. L. (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sciences, 63, PL113&#x2013;PL117. 10.1016/S0024-3205(98)00322-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(98)00322-1</ArticleId><ArticleId IdType="pubmed">9718088</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis, M. J. , Alexander, S. , Cirino, G. , Docherty, J. R. , George, C. H. , Giembycz, M. A. , Hoyer, D. , Insel, P. A. , Izzo, A. A. , Ji, Y. , MacEwan, D. J. , Sobey, C. G. , Stanford, S. C. , Teixeira, M. M. , Wonnacott, S. , &amp; Ahluwalia, A. (2018). Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175, 987&#x2013;993. 10.1111/bph.14153</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14153</ArticleId><ArticleId IdType="pmc">PMC5843711</ArticleId><ArticleId IdType="pubmed">29520785</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski, M. D. , Takei, H. , Schulz, P. E. , Appel, S. E. , &amp; Powell, S. Z. (2014). TDP&#x2010;43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathologica Communications, 2, 171. 10.1186/s40478-014-0171-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto, M. C. , &amp; Gurney, M. E. (1994). Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. The American Journal of Pathology, 145, 1271&#x2013;1279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887498</ArticleId><ArticleId IdType="pubmed">7992831</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Alessandro, G. , Catalano, M. , Sciaccaluga, M. , Chece, G. , Cipriani, R. , Rosito, M. , Grimaldi, A. , Lauro, C. , Cantore, G. , Santoro, A. , &amp; Fioretti, B. (2013). KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death &amp; Disease, 4, e773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763441</ArticleId><ArticleId IdType="pubmed">23949222</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalvi, P. S. , Chalmers, J. A. , Luo, V. , Han, D.&#x2010;Y. , Wellhauser, L. , Liu, Y. , Tran, D. Q. , Castel, J. , Luquet, S. , Wheeler, M. B. , &amp; Belsham, D. D. (2017). High fat induces acute and chronic inflammation in the hypothalamus: Effect of high&#x2010;fat diet, palmitate and TNF&#x2010;&#x3b1; on appetite&#x2010;regulating NPY neurons. International Journal of Obesity, 41, 149&#x2013;158. 10.1038/ijo.2016.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2016.183</ArticleId><ArticleId IdType="pubmed">27773938</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport, J. C. , Preux, P. M. , Truong, T. C. , Vallat, J. M. , Sautereau, D. , &amp; Couratier, P. (1999). Nutritional status is a prognostic factor for survival in ALS patients. Neurology, 53, 1059&#x2013;1063. 10.1212/WNL.53.5.1059</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst, J. , Schuster, J. , Dreyhaupt, J. , Witzel, S. , &amp; JH, Kassubek Jet al. (2020). Effect of high&#x2010;caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 91(9), 1007&#x2013;1009. 10.1136/jnnp-2020-323372</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323372</ArticleId><ArticleId IdType="pubmed">32788256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Oudart, H. , Ren&#xe9;, F. , Gonzalez de Aguilar, J. L. , &amp; Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high&#x2010;energy diet in a transgenic mouse model. Proceedings. National Academy of Sciences. United States of America, 101, 11159&#x2013;11164. 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli, M. , Battista, N. , Riganti, L. , Prada, I. , Antonucci, F. , Cantone, L. , Matteoli, M. , Maccarrone, M. , &amp; Verderio, C. (2015). Active endocannabinoids are secreted on extracellular membrane vesicles. EMBO Reports, 16, 213&#x2013;220. 10.15252/embr.201439668</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201439668</ArticleId><ArticleId IdType="pmc">PMC4328748</ArticleId><ArticleId IdType="pubmed">25568329</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;C&#xe1;ceres, C. , Balland, E. , Prevot, V. , Luquet, S. , Woods, S. C. , Koch, M. , Horvath, T. L. , Yi, C. X. , Chowen, J. A. , Verkhratsky, A. , &amp; Araque, A. (2018). Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism. Nature Neuroscience, 22, 7&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">30531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges, M. , Vercruysse, P. , M&#xfc;ller, H. P. , Huppertz, H. J. , Rosenbohm, A. , Nagel, G. , Weydt, P. , Peters&#xe9;n, &#xc5;. , Ludolph, A. C. , Kassubek, J. , &amp; Dupuis, L. (2017). Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 88, 1033&#x2013;1041. 10.1136/jnnp-2017-315795</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimaldi, A. , D'Alessandro, G. , Golia, M. T. , Gr&#xf6;ssinger, E. M. , Di Angelantonio, S. , Ragozzino, D. , Santoro, A. , Esposito, V. , Wulff, H. , Catalano, M. , &amp; Limatola, C. (2016). KCa3.1 inhibition switches the phenotype of glioma&#x2010;infiltrating microglia/macrophages. Cell Death &amp; Disease, 7, e2174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855657</ArticleId><ArticleId IdType="pubmed">27054329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, L. W. , Lucente, J. D. , Nguyen, H. M. , Singh, V. , Singh, L. , Chavez, M. , Bushong, T. , Wulff, H. , &amp; Maezawa, I. (2019). Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease. Annals of Clinical Translational Neurology, 6, 723&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469250</ArticleId><ArticleId IdType="pubmed">31019997</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren&#x2010;Shaul, H. , Spinrad, A. , Weiner, A. , Matcovitch&#x2010;Natan, O. , Dvir&#x2010;Szternfeld, R. , Ulland, T. K. , David, E. , Baruch, K. , Lara&#x2010;Astaiso, D. , Toth, B. , &amp; Itzkovitz, S. (2017). A unique microglia type associated with restricting development of Alzheimer's disease. Cell, 169, 1276&#x2013;1290.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkham, T. C. , Williams, C. M. , Fezza, F. , &amp; Di Marzo, V. (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2&#x2010;arachidonoyl glycerol. British Journal of Pharmacology, 136, 550&#x2013;557. 10.1038/sj.bjp.0704767</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0704767</ArticleId><ArticleId IdType="pmc">PMC1573386</ArticleId><ArticleId IdType="pubmed">12055133</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch, M. , Varela, L. , Kim, J. G. , Kim, J. D. , Hern&#xe1;ndez&#x2010;Nu&#xf1;o, F. , Simonds, S. E. , Castorena, C. M. , Vianna, C. R. , Elmquist, J. K. , Morozov, Y. M. , Rakic, P. , Bechmann, I. , Cowley, M. A. , Szigeti&#x2010;Buck, K. , Dietrich, M. O. , Gao, X. B. , Diano, S. , &amp; Horvath, T. L. (2015). Hypothalamic POMC neurons promote cannabinoid&#x2010;induced feeding. Nature, 519, 45&#x2013;50. 10.1038/nature14260</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14260</ArticleId><ArticleId IdType="pmc">PMC4496586</ArticleId><ArticleId IdType="pubmed">25707796</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalenko, I. , Glasauer, A. , Sch&#xf6;ckel, L. , Sauter, D. R. , Ehrmann, A. , Sohler, F. , H&#xe4;gebarth, A. , Novak, I. , &amp; Christian, S. (2016). Identification of KCa3.1 channel as a novel regulator of oxidative phosphorylation in a subset of pancreatic carcinoma cell lines. PLoS ONE, 11, e0160658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975431</ArticleId><ArticleId IdType="pubmed">27494181</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann, S. , Madore, C. , Cialic, R. , Baufeld, C. , Calcagno, N. , El Fatimy, R. , Beckers, L. , O'Loughlin, E. , Xu, Y. , Fanek, Z. , &amp; Greco, D. J. (2017). The TREM2&#x2010;APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity, 47, 566&#x2013;581.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauro, C. , Cipriani, R. , Catalano, M. , Trettel, F. , Chece, G. , Brusadin, V. , Antonilli, L. , van Rooijen, N. , Eusebi, F. , Fredholm, B. B. , &amp; Limatola, C. (2010). Adenosine A1 receptors and microglial cells mediate CX3CL1&#x2010;induced protection of hippocampal neurons against Glu&#x2010;induced death. Neuropsychopharmacology, 35, 1550&#x2013;1559. 10.1038/npp.2010.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2010.26</ArticleId><ArticleId IdType="pmc">PMC3055460</ArticleId><ArticleId IdType="pubmed">20200508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lay&#xe9;, S. , Gheusi, G. , Cremona, S. , Combe, C. , Kelley, K. , Dantzer, R. , &amp; Parnet, P. (2000). Endogenous brain IL&#x2010;1 mediates LPS&#x2010;induced anorexia and hypothalamic cytokine expression. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 279, R93&#x2013;R98. 10.1152/ajpregu.2000.279.1.R93</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.2000.279.1.R93</ArticleId><ArticleId IdType="pubmed">10896869</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Thuc, O. , Cansell, C. , Bourourou, M. , Denis, R. G. , Stobbe, K. , Devaux, N. , Guyon, A. , Cazareth, J. , Heurteaux, C. , Rost&#xe8;ne, W. , &amp; Luquet, S. (2016). Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation. EMBO Reports, 17, 1738&#x2013;1752. 10.15252/embr.201541499</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541499</ArticleId><ArticleId IdType="pmc">PMC5283585</ArticleId><ArticleId IdType="pubmed">27733491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilley, E. , Stanford, S. C. , Kendall, D. E. , Alexander, S. P. H. , Cirino, G. , Docherty, J. R. , George, C. H. , Insel, P. A. , Izzo, A. A. , Ji, Y. , Panettieri, R. A. , Sobey, C. G. , Stefanska, B. , Stephens, G. , Teixeira, M. , &amp; Ahluwalia, A. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. British Journal of Pharmacology, 177(16), 3611&#x2013;3616. 10.1111/bph.15178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15178</ArticleId><ArticleId IdType="pmc">PMC7393193</ArticleId><ArticleId IdType="pubmed">32662875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, N. K. , Moestrup, V. , Zhang, X. , Wang, W. A. , M&#xf8;ller, A. , &amp; Huang, F. D. (2018). An improved method for collection of cerebrospinal fluid from anesthetized mice. Journal of Visualized Experiments, 133, 56774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5931779</ArticleId><ArticleId IdType="pubmed">29608146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph, A. C. , Dorst, J. , Dreyhaupt, J. , Weishaupt, J. H. , Kassubek, J. , Weiland, U. , Meyer, T. , Petri, S. , Hermann, A. , Emmer, A. , Grosskreutz, J. , Grehl, T. , Zeller, D. , Boentert, M. , Schrank, B. , Prudlo, J. , Winkler, A. S. , Gorbulev, S. , Roselli, F. , &#x2026; for the LIPCAL&#x2010;ALS Study Group . (2020). Effect of high&#x2010;caloric nutrition on survival in amyotrophic lateral sclerosis. Annals of Neurology, 87, 206&#x2013;216. 10.1002/ana.25661</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin, B. , Desport, J. C. , Kajeu, P. , Jesus, P. , Nicolaud, B. , Nicol, M. , Preux, P. M. , &amp; Couratier, P. (2010). Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 628&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer, P. L. , &amp; McGeer, E. G. (2002). Inflammatory processes in amyotrophic lateral sclerosis. Muscle &amp; Nerve, 26, 459&#x2013;470. 10.1002/mus.10191</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia, C. , Calvo, A. , Grassano, M. , Canosa, A. , Manera, U. , D'Ovidio, F. , Bombaci, A. , Bersano, E. , Mazzini, L. , Mora, G. , Chi&#xf2;, A. Piemonte &amp; Valle d'Aosta Register for ALS (PARALS) . (2019). Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population&#x2010;based cohort. Journal of Neurology, Neurosurgery, and Psychiatry, 90, 666&#x2013;673. 10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison, H. W. , &amp; Filosa, J. A. (2013). A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. Journal of Neuroinflammation, 10, 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570327</ArticleId><ArticleId IdType="pubmed">23311642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo, S. T. , van Eijk, R. P. A. , Chachay, V. , van den Berg, L. H. , McCombe, P. A. , Henderson, R. D. , &amp; Steyn, F. J. (2019). Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, 497&#x2013;505. 10.1080/21678421.2019.1621346</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621346</ArticleId><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni, S. , Deng, J. , Jaffa, M. , Cudkowicz, M. E. , &amp; Wills, A. M. (2011). Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle &amp; Nerve, 44, 20&#x2013;24. 10.1002/mus.22114</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Percie du Sert, N. , Hurst, V. , Ahluwalia, A. , Alam, S. , Avey, M. T. , Baker, M. , Browne, W. J. , Clark, A. , Cuthill, I. C. , Dirnagl, U. , Emerson, M. , Garner, P. , Holgate, S. T. , Howells, D. W. , Karp, N. A. , Lazic, S. E. , Lidster, K. , MacCallum, C. J. , Macleod, M. , &#x2026; W&#xfc;rbel, H. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18(7), e3000410. 10.1371/journal.pbio.3000410</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000410</ArticleId><ArticleId IdType="pmc">PMC7360023</ArticleId><ArticleId IdType="pubmed">32663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps, M. E. , Huntley, G. W. , Hof, P. R. , Morrison, J. H. , &amp; Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences, 92, 689&#x2013;693. 10.1073/pnas.92.3.689</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D. R. , Siddique, T. , Patterson, D. , Figlewicz, D. A. , Sapp, P. , Hentati, A. , Donaldson, D. , Goto, J. , O'Regan, J. P. , Deng, H. X. , Rahmani, Z. , Krizus, A. , McKenna&#x2010;Yasek, D. , Cayabyab, A. , Gaston, S. M. , Berger, R. , Tanzi, R. E. , Halperin, J. J. , Herzfeldt, B. , &#x2026; Brown, R. H. Jr. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotropic lateral sclerosis. Nature, 362, 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu, T. , Nagaoka, U. , Nakayama, Y. , Kawata, A. , Kugimoto, C. , Kuroiwa, Y. , Kawai, M. , Shimohata, T. , Nishizawa, M. , Mihara, B. , Arahata, H. , Fujii, N. , Namba, R. , Ito, H. , Imai, T. , Nobukuni, K. , Kondo, K. , Ogino, M. , Nakajima, T. , &amp; Komori, T. (2012). Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan. Amyotrophic Lateral Sclerosis, 13, 363&#x2013;366. 10.3109/17482968.2012.678366</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678366</ArticleId><ArticleId IdType="pubmed">22632442</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott, E. O. , Malek, A. M. , &amp; Lacomis, D. (2016). The epidemiology of amyotrophic lateral sclerosis. Handbook of Clinical Neurology, 138, 225&#x2013;238. 10.1016/B978-0-12-802973-2.00013-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuc, O. L. , Stobbe, K. , Cansell, C. , Nahon, J. L. , Blondeau, N. , &amp; Rov&#xe8;re, C. (2017). Hypothalamic inflammation and energy balance disruptions: Spotlight on chemokines. Frontiers in Endocrinology, 8, 197. 10.3389/fendo.2017.00197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00197</ArticleId><ArticleId IdType="pmc">PMC5557773</ArticleId><ArticleId IdType="pubmed">28855891</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama, K. , Wulff, H. , Chandy, K. G. , Azam, P. , Raman, G. , Saito, T. , Fujiwara, Y. , Mattson, D. L. , Das, S. , Melvin, J. E. , Pratt, P. F. , Hatoum, O. A. , Gutterman, D. D. , Harder, D. R. , &amp; Miura, H. (2008). The intermediate&#x2010;conductance calcium&#x2010;activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. The Journal of Clinical Investigation, 118, 3025&#x2013;3037. 10.1172/JCI30836</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30836</ArticleId><ArticleId IdType="pmc">PMC2496961</ArticleId><ArticleId IdType="pubmed">18688283</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdearcos, M. , Douglass, J. D. , Robblee, M. M. , Dorfman, M. D. , Stifler, M. R. , Bennett, M. L. , Gerritse, I. , Fasnacht, R. , Barres, B. A. , Thaler, J. P. , &amp; Koliwad, S. K. (2017). Microglial inflammatory signaling orchestrates the hypothalamic immune response to dietary excess and mediates obesity susceptibility. Cell Metabolism, 26, 185&#x2013;197.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5569901</ArticleId><ArticleId IdType="pubmed">28683286</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse, P. , Sinniger, J. , Oussini, H. E. , Scekic&#x2010;Zahirovic, J. , &amp; Dieterl&#xe9;, S. (2016). Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain, 139, 1106&#x2013;1122. 10.1093/brain/aww004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, P. , Loh, K. H. , Wu, M. , Morgan, D. A. , Schneeberger, M. , Yu, X. , Chi, J. , Kosse, C. , Kim, D. , Rahmouni, K. , Cohen, P. , &amp; Friedman, J. (2020). A leptin&#x2013;BDNF pathway regulating sympathetic innervation of adipose tissue. Nature, 583, 839&#x2013;844. 10.1038/s41586-020-2527-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2527-y</ArticleId><ArticleId IdType="pubmed">32699414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska, I. (2009). TDP&#x2010;43 mutant mice develop features of ALS and frontotemporal lobar degeneration. Proceedings of the National Academy of Sciences, 106, 18809&#x2013;18814. 10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt, P. , Hong, S. Y. , Kliot, M. , &amp; Moller, T. (2003). Assessing disease onset and progression in the SOD1 mouse model of ALS. Neurology Report, 14, 1051&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills, A. M. , Hubbard, J. , Macklin, E. A. , Glass, J. , Tandan, R. , Simpson, E. P. , Brooks, B. , Gelinas, D. , Mitsumoto, H. , Mozaffar, T. , Hanes, G. P. , Ladha, S. S. , Heiman&#x2010;Patterson, T. , Katz, J. , Lou, J. S. , Mahoney, K. , Grasso, D. , Lawson, R. , Yu, H. , &#x2026; MDA Clinical Research Network . (2014). Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: A randomised, double&#x2010;blind, placebo&#x2010;controlled phase 2 trial. Lancet, 383, 2065&#x2013;2072. 10.1016/S0140-6736(14)60222-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisse, B. E. , Ogimoto, K. , Tang, J. , Harris, M. K. , Raines, E. W. , &amp; Schwartz, M. W. (2007). Evidence that lipopolysaccharide&#x2010;induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology, 148, 5230&#x2013;5237. 10.1210/en.2007-0394</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2007-0394</ArticleId><ArticleId IdType="pubmed">17673516</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulff, H. , Miller, M. J. , Hansel, W. , Grissmer, S. , Cahalan, M. D. , &amp; Chandy, K. G. (2000). Design of a potent and selective inhibitor of the intermediate&#x2010;conductance Ca2+&#x2010;activated K+ channel, IKCa1: A potential immunosuppressant. Proc Natl Acad Sci U S A, 97, 8151&#x2013;8156. 10.1073/pnas.97.14.8151</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.14.8151</ArticleId><ArticleId IdType="pmc">PMC16685</ArticleId><ArticleId IdType="pubmed">10884437</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, B. , &amp; Xie, X. (2016). Neurotrophic factor control of satiety and body weight. Nature Reviews. Neuroscience, 17, 282&#x2013;292. 10.1038/nrn.2016.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.24</ArticleId><ArticleId IdType="pmc">PMC4898883</ArticleId><ArticleId IdType="pubmed">27052383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo, G. S. , &amp; Heisler, L. K. (2012). Unraveling the brain regulation of appetite: Lessons from genetics. Nature Neuroscience, 15, 1343&#x2013;1349. 10.1038/nn.3211</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3211</ArticleId><ArticleId IdType="pubmed">23007189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>